Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Ukraine

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Ukraine Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20063
20075
20084
20091
20107
20116
20125
20136
20141
20151
20164
20176
20181
20196
20201
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Terminated10
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Alkermes, Inc.7
Sumitomo Pharma America, Inc.7
Janssen Research & Development, LLC6
H. Lundbeck A/S5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
ACADIA Pharmaceuticals Inc.3
FORUM Pharmaceuticals Inc3
Forest Laboratories3
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia64
Psychotic Disorders4
Cognition Disorders3
Mental Disorders3
Bipolar Disorder2
Autistic Disorder1
Mania1
Recurrence1

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.